Raborn, L.N.
Burke, A.B.
Ebb, D.H.
Collins, M.T.
Kaban, L.B.
Boyce, A.M. http://orcid.org/0000-0003-2987-3887
Funding for this research was provided by:
National Institute of Dental and Craniofacial Research (Z01 DE000649)
Article History
Received: 6 October 2020
Accepted: 16 February 2021
First Online: 27 March 2021
Declarations
:
: The patient in this study was seen as part of a natural history study approved by the Investigational Review Board of the NIDCR, NIH (NCT00001727). Informed assent and consent were obtained from the patient and her guardians.
: NIDCR receives support from Amgen, Inc for an investigator-sponsored study of denosumab for fibrous dysplasia (Alison Boyce, Michael Collins). Layne Raborn, Andrea Burke, David Ebb, and Leonard Kaban report no conflicts of interest.